208 related articles for article (PubMed ID: 30172956)
21. Cutaneous peripheral T-cell lymphoma, not otherwise specified: A single-center prognostic analysis.
Tolkachjov SN; Weenig RH; Comfere NI
J Am Acad Dermatol; 2016 Nov; 75(5):992-999. PubMed ID: 27498959
[TBL] [Abstract][Full Text] [Related]
22. Ratio of peripheral blood absolute lymphocyte count to absolute monocyte count at diagnosis is associated with progression-free survival in follicular lymphoma.
Kumagai S; Tashima M; Fujikawa J; Iwasaki M; Iwamoto Y; Sueki Y; Fukunaga A; Yanagita S; Nishikori M; Takaori-Kondo A; Arima N
Int J Hematol; 2014 Jun; 99(6):737-42. PubMed ID: 24756873
[TBL] [Abstract][Full Text] [Related]
23. High Level of Serum Soluble Interleukin-2 Receptor Is Associated With Poor Survival in Patients With First Relapsed or Refractory Peripheral T-Cell Lymphoma, Not Otherwise Specified: A Retrospective Study.
Morita-Fujita M; Katoh D; Shimomura Y; Ishikawa T
Clin Lymphoma Myeloma Leuk; 2019 Jul; 19(7):e337-e342. PubMed ID: 31053551
[TBL] [Abstract][Full Text] [Related]
24. Prognostic significance of absolute lymphocyte count/absolute monocyte count ratio at diagnosis in patients with multiple myeloma.
Shin SJ; Roh J; Kim M; Jung MJ; Koh YW; Park CS; Yoon DH; Suh C; Park CJ; Chi HS; Huh J
Korean J Pathol; 2013 Dec; 47(6):526-33. PubMed ID: 24421845
[TBL] [Abstract][Full Text] [Related]
25. Analysis of prognostic factors in peripheral T-cell lymphoma: prognostic value of serum albumin and mediastinal lymphadenopathy.
Chihara D; Oki Y; Ine S; Yamamoto K; Kato H; Taji H; Kagami Y; Yatabe Y; Nakamura S; Morishima Y
Leuk Lymphoma; 2009 Dec; 50(12):1999-2004. PubMed ID: 19860627
[TBL] [Abstract][Full Text] [Related]
26. Prognostic significance of peripheral monocyte count in patients with extranodal natural killer/T-cell lymphoma.
Huang JJ; Li YJ; Xia Y; Wang Y; Wei WX; Zhu YJ; Lin TY; Huang HQ; Jiang WQ; Li ZM
BMC Cancer; 2013 May; 13():222. PubMed ID: 23638998
[TBL] [Abstract][Full Text] [Related]
27. The Role of Lymphocyte to Monocyte Ratio, Microvessel Density and HiGH CD44 Tumor Cell Expression in Non Hodgkin Lymphomas.
Jelicic J; Balint MT; Jovanovic MP; Boricic N; Micev M; Stojsic J; Antic D; Andjelic B; Bila J; Balint B; Pavlovic S; Mihaljevic B
Pathol Oncol Res; 2016 Jul; 22(3):567-77. PubMed ID: 26750138
[TBL] [Abstract][Full Text] [Related]
28. CHOP or THP-COP regimens in the treatment of newly diagnosed peripheral T-cell lymphoma, not otherwise specified: a comparison of doxorubicin and pirarubicin.
Shibata Y; Hara T; Kasahara S; Yamada T; Sawada M; Mabuchi R; Matsumoto T; Nakamura N; Nakamura H; Ninomiya S; Kitagawa J; Kanemura N; Kito Y; Goto N; Miyazaki T; Takami T; Takeuchi T; Shimizu M; Tsurumi H
Hematol Oncol; 2017 Jun; 35(2):163-171. PubMed ID: 26449182
[TBL] [Abstract][Full Text] [Related]
29. Peripheral blood absolute lymphocyte/monocyte ratio recovery during ABVD treatment cycles predicts clinical outcomes in classical Hodgkin lymphoma.
Porrata LF; Ristow KM; Habermann TM; Macon WR; Witzig TE; Colgan JP; Inwards DJ; Ansell SM; Micallef IN; Johnston PB; Nowakowski G; Thompson CA; Markovic SN
Blood Cancer J; 2013 Apr; 3(4):e110. PubMed ID: 23599022
[TBL] [Abstract][Full Text] [Related]
30. The lower peripheral blood lymphocyte/monocyte ratio assessed during routine follow-up after standard first-line chemotherapy is a risk factor for predicting relapse in patients with diffuse large B-cell lymphoma.
Yan-Li L; Kang-Sheng G; Yue-Yin P; Yang J; Zhi-Min Z
Leuk Res; 2014 Mar; 38(3):323-8. PubMed ID: 24439567
[TBL] [Abstract][Full Text] [Related]
31. The prognostic impact of absolute lymphocyte and monocyte counts at diagnosis of diffuse large B-cell lymphoma in the rituximab era.
Aoki K; Tabata S; Yonetani N; Matsushita A; Ishikawa T
Acta Haematol; 2013; 130(4):242-6. PubMed ID: 23860478
[TBL] [Abstract][Full Text] [Related]
32. Peripheral blood absolute lymphocyte/monocyte ratio as a useful prognostic factor in diffuse large B-cell lymphoma in the rituximab era.
Watanabe R; Tomita N; Itabashi M; Ishibashi D; Yamamoto E; Koyama S; Miyashita K; Takahashi H; Nakajima Y; Hattori Y; Motohashi K; Takasaki H; Ohshima R; Hashimoto C; Yamazaki E; Fujimaki K; Sakai R; Fujisawa S; Motomura S; Ishigatsubo Y
Eur J Haematol; 2014 Mar; 92(3):204-10. PubMed ID: 24283206
[TBL] [Abstract][Full Text] [Related]
33. Profiles of serum cytokines and their clinical implications in patients with peripheral T-cell lymphoma.
Yi JH; Ryu KJ; Ko YH; Kim WS; Kim SJ
Cytokine; 2019 Jan; 113():371-379. PubMed ID: 30327172
[TBL] [Abstract][Full Text] [Related]
34. Survival of patients with peripheral T-cell lymphoma after first relapse or progression: spectrum of disease and rare long-term survivors.
Mak V; Hamm J; Chhanabhai M; Shenkier T; Klasa R; Sehn LH; Villa D; Gascoyne RD; Connors JM; Savage KJ
J Clin Oncol; 2013 Jun; 31(16):1970-6. PubMed ID: 23610113
[TBL] [Abstract][Full Text] [Related]
35. Peripheral blood absolute lymphocyte/monocyte ratio during rituximab, cyclophosphamide, doxorubicin, vincristine and prednisone treatment cycles predicts clinical outcomes in diffuse large B-cell lymphoma.
Porrata LF; Ristow KM; Habermann TM; Witzig TE; Colgan JP; Inwards DJ; Ansell SM; Micallef IN; Johnston PB; Nowakowski G; Thompson CA; Markovic SN
Leuk Lymphoma; 2014 Dec; 55(12):2728-38. PubMed ID: 24547705
[TBL] [Abstract][Full Text] [Related]
36. Proteomic profiling identifies outcome-predictive markers in patients with peripheral T-cell lymphoma, not otherwise specified.
Ludvigsen M; Bjerregård Pedersen M; Lystlund Lauridsen K; Svenstrup Poulsen T; Hamilton-Dutoit SJ; Besenbacher S; Bendix K; Møller MB; Nørgaard P; d'Amore F; Honoré B
Blood Adv; 2018 Oct; 2(19):2533-2542. PubMed ID: 30291111
[TBL] [Abstract][Full Text] [Related]
37. Absolute monocyte and lymphocyte count prognostic score for patients with gastric cancer.
Eo WK; Jeong DW; Chang HJ; Won KY; Choi SI; Kim SH; Chun SW; Oh YL; Lee TH; Kim YO; Kim KH; Ji YI; Kim A; Kim HY
World J Gastroenterol; 2015 Mar; 21(9):2668-76. PubMed ID: 25759535
[TBL] [Abstract][Full Text] [Related]
38. The clinical significance of activated p-AKT expression in peripheral T-cell lymphoma.
Hong JY; Hong ME; Choi MK; Chang W; Do IG; Jo JS; Jung SH; Park S; Kim SJ; Ko YH; Kim WS
Anticancer Res; 2015 Apr; 35(4):2465-74. PubMed ID: 25862915
[TBL] [Abstract][Full Text] [Related]
39. Increased incidence of adult T cell leukemia-lymphoma and peripheral T cell lymphoma-not otherwise specified with limited improvement in overall survival: a retrospective analysis using data from the population-based Osaka Cancer Registry.
Fuji S; Kida S; Nakata K; Morishima T; Miyashiro I; Ishikawa J
Ann Hematol; 2021 Jan; 100(1):157-165. PubMed ID: 33089366
[TBL] [Abstract][Full Text] [Related]
40. Peripheral blood lymphocyte/monocyte ratio at diagnosis and survival in nodular lymphocyte-predominant Hodgkin lymphoma.
Porrata LF; Ristow K; Habermann TM; Witzig TE; Colgan JP; Inwards DJ; Ansell SM; Micallef IN; Johnston PB; Nowakowski GS; Thompson C; Markovic SN
Br J Haematol; 2012 May; 157(3):321-30. PubMed ID: 22360654
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
